May 8, 2018 / 10:39 PM / 2 months ago

BRIEF-Corcept Therapeutics Reports Qtrly Revenue $57.7 Million

May 8 (Reuters) - Corcept Therapeutics Inc:

* REPORTS QTRLY REVENUE $57.7 MILLION

* CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q1 NON-GAAP EARNINGS PER SHARE $0.19

* SEES FY 2018 REVENUE $275 MILLION TO $300 MILLION

* Q1 REVENUE $57.7 MILLION VERSUS I/B/E/S VIEW $58.2 MILLION

* Q1 EARNINGS PER SHARE VIEW $0.16 — THOMSON REUTERS I/B/E/S

* REAFFIRMED 2018 REVENUE GUIDANCE OF $275 - 300 MILLION

* FY2018 REVENUE VIEW $290.2 MILLION — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below